DHI Group, Inc. (DHX) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by DHI Group, Inc. on January 27, 2021, with the earliest event reported on the same date. The filing addresses changes to the composition of the Company's Board of Directors.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The only financial data disclosed relates to director compensation:
- Annual Board Fee: $35,000 for Kathleen M. Swann (prorated).
- Committee Fee: $5,000 for service on the Compensation Committee (prorated).
- Equity Grant: Prorated grant of 11,223 shares of restricted stock to Ms. Swann.
Material Changes
The following changes to the Board of Directors were effective January 27, 2021:
- Resignation: Carol Carpenter resigned as a director, effective January 31, 2021. The filing states this was not the result of any disagreement with the Company.
- Appointment: Kathleen M. Swann was appointed as a Class II director to stand for re-election at the 2021 Annual Meeting.
- Reclassification: CEO Art Zeile resigned as a Class II director and was immediately reappointed as a Class I director to rebalance board classes.
Outlook, Risks, and Management Commentary
The filing includes a Regulation FD disclosure referencing a press release issued on January 29, 2021. No specific financial guidance, risk factors, or unusual items were disclosed in this report. The Company confirmed there are no currently proposed transactions involving Ms. Swann or her immediate family requiring reporting under Item 404(a) of Regulation S-K.
Key Facts for Investor Verification
- Verify the effective date of Carol Carpenter's resignation (January 31, 2021) and the immediate appointment of Kathleen M. Swann.
- Confirm the total number of board seats and the specific class structure following the reclassification of Art Zeile.
- Review the attached press release (Exhibit 99.1) for additional context on the board changes.
- Note that Ms. Swann's equity grant is prorated and subject to future awards consistent with other independent directors.